Filing Details

Accession Number:
0001062993-22-024287
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-21 16:15:40
Reporting Period:
2022-12-19
Accepted Time:
2022-12-21 16:15:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1603454 Celcuity Inc. CELC Services-Medical Laboratories (8071) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1688319 E Richard Buller 16305 36Th Avenue North
Suite 100
Minneapolis MN 55446
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-19 300 $11.11 9,148 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $5.10 2030-05-14 12,654 12,654 Direct
Common Stock Stock Option (right to buy) $5.50 2029-12-03 4,555 4,555 Direct
Common Stock Stock Option (right to buy) $5.50 2031-05-12 2,310 2,310 Direct
Common Stock Stock Option (right to buy) $5.50 2032-05-17 19,558 19,558 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2030-05-14 12,654 12,654 Direct
2029-12-03 4,555 4,555 Direct
2031-05-12 2,310 2,310 Direct
2032-05-17 19,558 19,558 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.09 to $11.235, inclusive. The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.
  4. 100% vested.
  5. This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.